1. Home
  2. VTYX vs MPTI Comparison

VTYX vs MPTI Comparison

Compare VTYX & MPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTYX
  • MPTI
  • Stock Information
  • Founded
  • VTYX 2018
  • MPTI 1965
  • Country
  • VTYX United States
  • MPTI United States
  • Employees
  • VTYX N/A
  • MPTI N/A
  • Industry
  • VTYX Medicinal Chemicals and Botanical Products
  • MPTI
  • Sector
  • VTYX Health Care
  • MPTI
  • Exchange
  • VTYX Nasdaq
  • MPTI Nasdaq
  • Market Cap
  • VTYX 154.9M
  • MPTI 127.2M
  • IPO Year
  • VTYX 2021
  • MPTI N/A
  • Fundamental
  • Price
  • VTYX $2.74
  • MPTI $44.76
  • Analyst Decision
  • VTYX Buy
  • MPTI
  • Analyst Count
  • VTYX 2
  • MPTI 0
  • Target Price
  • VTYX $9.00
  • MPTI N/A
  • AVG Volume (30 Days)
  • VTYX 776.8K
  • MPTI 48.3K
  • Earning Date
  • VTYX 08-07-2025
  • MPTI 08-12-2025
  • Dividend Yield
  • VTYX N/A
  • MPTI N/A
  • EPS Growth
  • VTYX N/A
  • MPTI 45.88
  • EPS
  • VTYX N/A
  • MPTI 2.57
  • Revenue
  • VTYX N/A
  • MPTI $52,033,000.00
  • Revenue This Year
  • VTYX N/A
  • MPTI $11.13
  • Revenue Next Year
  • VTYX N/A
  • MPTI $8.24
  • P/E Ratio
  • VTYX N/A
  • MPTI $17.46
  • Revenue Growth
  • VTYX N/A
  • MPTI 16.52
  • 52 Week Low
  • VTYX $0.78
  • MPTI $27.50
  • 52 Week High
  • VTYX $3.39
  • MPTI $60.00
  • Technical
  • Relative Strength Index (RSI)
  • VTYX 51.07
  • MPTI 54.87
  • Support Level
  • VTYX $2.38
  • MPTI $41.00
  • Resistance Level
  • VTYX $3.05
  • MPTI $43.47
  • Average True Range (ATR)
  • VTYX 0.22
  • MPTI 1.86
  • MACD
  • VTYX -0.02
  • MPTI -0.04
  • Stochastic Oscillator
  • VTYX 55.15
  • MPTI 65.14

About VTYX Ventyx Biosciences Inc.

Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.

About MPTI M-tron Industries Inc.

M-Tron Industries Inc is a diversified holding company with subsidiaries engaged in designing, manufacturing, and marketing high-engineered, high-reliability frequency and spectrum control products used to control the frequency or timing of signals in electronic circuits in various applications. The company's serving markets are aerospace and defense, space, and avionics. The company offers products such as microwave and millimeter wave filters; cavity, crystal, ceramic, lumped element, and switched filters; crystal resonators, integrated microwave assemblies, and solid-state power amplifier products.

Share on Social Networks: